Steroid-induced resolution of refractory pulmonary interstitial emphysema

J Matern Fetal Neonatal Med. 2016 Dec;29(24):4092-5. doi: 10.3109/14767058.2016.1159673. Epub 2016 Mar 29.

Abstract

Pulmonary interstitial emphysema (PIE) is a familiar complication of mechanical ventilation in premature infants. Its most severe form, marked by life-threatening respiratory and cardiovascular compromise, is a particularly vexing problem in neonatology. Treatment modalities rely on decubitus positioning and reduction of mean airway pressure, but refractory PIE is unresponsive to these maneuvers. Other options such as selective unilateral bronchial intubation, balloon catheter bronchial occlusion, selective lung volume reduction, and mechanical decompression each have clear limitations. In a patient with refractory, life-threatening PIE too unstable for other therapeutic modalities, we describe success with steroid therapy at a familiar dosing regimen.

Keywords: Hydrocortisone; pneumothorax; pulmonary interstitial emphysema; respiratory distress syndrome; steroids.

Publication types

  • Case Reports

MeSH terms

  • Anti-Inflammatory Agents / administration & dosage*
  • Continuous Positive Airway Pressure / adverse effects*
  • Humans
  • Hydrocortisone / administration & dosage*
  • Infant, Extremely Low Birth Weight
  • Infant, Extremely Premature
  • Infant, Newborn
  • Intensive Care Units, Neonatal
  • Lung / diagnostic imaging
  • Male
  • Pulmonary Emphysema / complications
  • Pulmonary Emphysema / drug therapy*
  • Radiography
  • Respiratory Distress Syndrome, Newborn / drug therapy*
  • Respiratory Distress Syndrome, Newborn / etiology

Substances

  • Anti-Inflammatory Agents
  • Hydrocortisone

Supplementary concepts

  • Respiratory Distress Syndrome In Premature Infants